Ad is loading...
HMVCX vs JVMSX
HMVCX vs JVMSX Comparison
Open Charts HMVCX vs JVMSX
Hartford MidCap Value C
Price$10.00
Change+$0.11 (+1.11%)
VolumeN/A
Net Assets1.07B
JHancock Disciplined Value Mid Cap R2
Price$26.42
Change+$0.26 (+0.99%)
VolumeN/A
Net Assets20.63B
HMVCX vs JVMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HMVCX vs. JVMSX commentary
May 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVCX is a Buy and JVMSX is a Buy.
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 20.6B vs. HMVCX (1.07B). JVMSX pays higher dividends than HMVCX: JVMSX (0.46) vs HMVCX (0.28). HMVCX was incepted earlier than JVMSX: HMVCX (24 years) vs JVMSX (13 years). HMVCX (1.95) is less costly to investors than JVMSX (1.26). HMVCX is a more actively managed with annual turnover of: 132.00 vs. JVMSX (47.00). JVMSX has a lower initial minimum investment than HMVCX: JVMSX (0) vs HMVCX (2000). JVMSX annual gain was more profitable for investors over the last year : -8.45 vs. HMVCX (-17.57). JVMSX return over 5 years is better than : 50.94 vs. HMVCX (8.89).
| HMVCX | JVMSX | HMVCX / JVMSX | |
| Total Expense Ratio | 1.95 | 1.25 | 156% |
| Annual Report Gross Expense Ratio | 1.95 | 1.26 | 155% |
| Fund Existence | 24 years | 13 years | - |
| Gain YTD | -7.880 | -2.424 | 325% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.07B | 20.6B | 5% |
| Annual Yield % from dividends | 0.28 | 0.46 | 62% |
| Returns for 1 year | -17.57 | -8.45 | 208% |
| Returns for 3 years | -24.37 | 4.66 | -523% |
| Returns for 5 years | 8.89 | 50.94 | 17% |
| Returns for 10 years | -28.37 | 27.80 | -102% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 78.04 | 0.69 | +0.89% |
| SPDR® S&P Biotech ETF | |||
| XBAP | 35.08 | 0.15 | +0.44% |
| Innovator US Eq Acltd 9 Bfr ETFTM April | |||
| MARW | 31.14 | 0.11 | +0.34% |
| AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
| DFSI | 37.11 | -0.01 | -0.02% |
| Dimensional International Sstby Cr 1 ETF | |||
| BFIX | 25.14 | -0.08 | -0.30% |
| Build Bond Innovation ETF | |||